Taken together, our results shed light on a novel intersection of ApoA5 and the ANGPTL3/4/8 family of proteins in the regulation of TG metabolism and also provide a possible explanation for LXR agonist–induced hypertriglyceridemia. The gene discussed is ANGPTL3; the disease is hypertriglyceridemia.